Search clinical trials for: Poly(ADP-ribose) Polymerase Inhibitors
Total 2237 results
-
Sarah E TaylorAmerican Society of Clinical OncologyTerminatedOvarian CancerUnited States
-
Arcagy ResearchBelgian Gynaecological Oncology Group; Grupo Español de Investigación en Cáncer... and other collaboratorsCompletedOvarian CancerFrance, Germany, Austria, Denmark, Italy, Japan, Finland, Spain, Monaco, Sweden, Belgium
-
AbbVieNo longer availableHigh Grade Serous Ovarian Cancer | Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound | Triple Negative Breast Cancer (TNBC) | Patients Requiring Veliparib Suspension Formulation
-
Grupo Español de Investigación en Cáncer de OvarioCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerSpain
-
National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedAdvanced Breast Cancer | Advanced Solid Tumors | Primary Peritoneal Cancer | Advanced Ovarian CancerUnited States
-
Jihong LiuUnknownPlatinum-resistant Ovarian CancerChina
-
Laval UniversityTerminated
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal CancerUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustUnknownAdenocarcinoma of the ProstateUnited Kingdom
-
PfizerCompleted
-
Massachusetts General HospitalCompleted
-
Tesaro, Inc.WithdrawnLymphoma | Mantle-Cell
-
PfizerWithdrawnDiabetes Mellitus | Diabetic Retinopathy
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompleted
-
Xiaoxiang ChenRecruitingOvarian Cancer | PARP Inhibitor | Clinical MarkerChina
-
AstraZenecaCompletedOvarian Neoplasms | BRCA1 Protein | BRCA2 ProteinNetherlands, Belgium, United Kingdom, Poland
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedOvarian NeoplasmUnited States, Spain, Australia, Germany, Sweden
-
MedSIRNot yet recruitingOvarian Cancer | Oligometastatic Disease | Serous Ovarian Tumor
-
Alexander B Olawaiye, MDAstraZenecaRecruiting
-
Azienda Ospedaliero-Universitaria di ModenaRecruitingMetastatic Pancreatic Cancer | Advanced Pancreatic CancerItaly
-
PfizerNot yet recruitingBreast Neoplasms
-
Hospices Civils de LyonNot yet recruitingAdvanced Malignant Pleural or Peritoneal Mesothelioma
-
Dana-Farber Cancer InstituteAstraZeneca; Osteosarcoma InstituteRecruitingOsteosarcoma | Osteosarcoma RecurrentUnited States
-
pharmaand GmbHCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Other Solid Tumor | Metastatic Castration-Resistant Prostate CancerIsrael, Italy, Canada, Russian Federation, United Kingdom, Poland
-
Bai-Rong XiaActive, not recruiting
-
University of Colorado, DenverNational Cancer Institute (NCI); Clovis Oncology, Inc.Active, not recruitingMetastatic Endometrial CancerUnited States
-
University of FloridaGlaxoSmithKlineCompletedRenal Cell Carcinoma | Mesothelioma | Cholangiocarcinoma | Uveal MelanomaUnited States
-
zr Pharma & GmbHFoundation MedicineTerminatedBladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Muscle Invasive Bladder Cancer | Ureter Carcinoma | Renal Pelvis Carcinoma | Urinary Bladder Carcinoma | Urethra CarcinomaUnited States, Spain, France, Italy, Germany, United Kingdom
-
AstraZenecaCompletedRefractory Solid Tumours | Relapsed Small Cell Lung Cancer (SCLC)United States, Canada
-
Institut Paoli-CalmettesGlaxoSmithKlineNot yet recruiting
-
Nader SanaiGlaxoSmithKline; University of California, San Francisco; Barrow Neurological... and other collaboratorsRecruitingGlioma | Glioblastoma | Glioblastoma Multiforme | GBM | Glioma, Malignant | Glioblastoma Multiforme of BrainUnited States
-
Massachusetts General HospitalTesaro, Inc.RecruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingOral Squamous Cell Carcinoma (OSCC)United States
-
Richard ZellarsCompleted
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZenecaActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | Somatic Mutation Breast Cancer (BRCA1) | Somatic Mutation Breast Cancer (BRCA2)United States
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedBreast NeoplasmsSweden, United States, United Kingdom, Germany, Spain, Australia, Israel, Canada
-
University of Michigan Rogel Cancer CenterActive, not recruitingProstate CancerUnited States
-
zr Pharma & GmbHCompletedAdvanced Solid TumorJapan
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompleted
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
PfizerMedivation, Inc.CompletedAcute Myeloid Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic SyndromeUnited Kingdom, United States
-
National Center for Tumor Diseases, HeidelbergAstraZeneca; German Cancer Research Center; PharmaMarCompletedCancers With DNA Repair-DeficiencyGermany
-
The University of Texas Health Science Center at...WithdrawnCancer of the Breast
-
Zhejiang Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingFemale Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Not yet recruiting
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
National Cancer Institute, NaplesRecruiting
-
AstraZenecaRecruitingOvarian CancerChina, Vietnam, Russian Federation, Ukraine, South Africa, Turkey, India, Peru, Colombia, Poland, Chile, Philippines